India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hous Dev 1641.60 0.58
Wipro Lt 286.40 6.47
Reliance 1586.20 3.76
Icici Ba 301.20 0.22
Ntpc Ltd 164.35 0.57
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Cadila Healthcare Limited
Cadila Healthcare Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:532321NSE:CADILAHCBloomberg:CDH@INReuters:CADI.BO
Market Lot: 1Face Value: 1ISIN Demat: INE010B01027
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
19-Jul-2017       Zydus receives final approval from USFDA for Tranexamic Acid injection IRIS
19-Jul-2017       Zydus Cadila launches Mesalamine delayed release tablets in US IRIS
17-Jul-2017       Zydus Cadila receives approval from USFDA for Fingolimod capsules IRIS
12-Jul-2017       Zydus Cadilla receives USFDA nod for Memantine HCl tablets IRIS
10-Jul-2017       Zydus Cadila receives USFDA nod to market Doxazosin tablets IRIS
06-Jul-2017       Zydus Cadila plans to enter into long-term arrangement with Phibro IRIS
04-Jul-2017       Zydus Cadila receives USFDA approval for 2 anti-diabetic drugs IRIS
30-Jun-2017       Zydus Cadila gets USFDAs final nod for Phentermine HCl tablets IRIS
29-Jun-2017       Zydus Cadila receives USFDA approval for ADHD drug IRIS
28-Jun-2017       Zydus Cadila receives final approval for Oxybutynin Chloride ER tablets IRIS
27-Jun-2017       Zydus Cadila receives final approval for Entecavir tablets IRIS
21-Jun-2017       Zydus Cadila receives EIR for Moraiya manufacturing facility IRIS
20-Jun-2017       Zydus Cadilla gets USFDAs final nod for Diflunisal tablets IRIS
20-Jun-2017       Zydus receives final approval from the USFDA for Diflunisal Tablets IRIS
19-Jun-2017       Zydus receives USFDAs final nod for Eletriptan HCl tablets IRIS
15-Jun-2017       Zydus Cadila receives USFDA approval for Acyclovir injection IRIS
13-Jun-2017       Zydus Cadila receives USFDA's final nod for Ezetimibe tablets IRIS
12-Jun-2017       Zydus Pharma's arm gets final nod for Nystatin topical powder IRIS
07-Jun-2017       Zydus Cadila gets USFDA final approval for Mesalamine tablets IRIS
06-Jun-2017       Cadila Healthcare gains on receiving EIR from USFDA for Baddi facility IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer